人工智能引导的纳米粒子设计,用于先进的向药物输送
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
BioImpacts : BI
|February 20, 2026
概括
人工智能 (AI) 可以准确地预测纳米粒子 (NP) 设计用于向治疗,改善药物输送和优化结果. 将人工智能集成到纳米医学中可以加速临床试验,并增强个性化治疗.
科学领域:
- 制药纳米技术的应用
- 医学纳米技术 医学纳米技术
- 药物输送系统是药物输送系统.
背景情况:
- 纳米粒子 (NP) 对于向治疗至关重要,但对其属性的精确控制 (大小,泽塔潜力,表面修饰) 是具有挑战性的.
- 传统的试错 NP 开发方法比基于智能工具的方法耗时且效率较低.
研究的目的:
- 探索人工智能 (AI) 在预测针对性疾病治疗的纳米粒子结构设计方面的关键作用.
- 突出AI在优化NP配方和加速临床试验方面的潜力.
主要方法:
- 利用人工智能技术,如监督学习,深度神经网络,图形神经网络和生成模型.
- 应用人工智能来预测NP行为并优化药物加载效率和mRNA输送.
主要成果:
- 人工智能在提高药物加载效率和促进mRNA药物递送方面显示出巨大的潜力.
- 人工智能驱动的NP行为预测可以优化配方并加快药物开发过程.
结论:
- 人工智能集成对于通过精确的纳米粒子设计和控制来实现个性化治疗至关重要.
- 解决数据质量,模型解释性,伦理和协作方面的挑战对于人工智能在纳米医学中的成功实施至关重要.
- 编辑主张将AI适当整合到制药和医疗纳米技术中,以推进医疗保健.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
91
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
91
Site-Targeted Drug Delivery Systems: Polymeric Carriers
106
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
106


